Prescription drug · ANDA
Doxazosin NDC 70771-1115
Doxazosin mesylate 8 mg/1 · Tablet · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1115-0 | 70771111500 | 1000 TABLET in 1 BOTTLE (70771-1115-0)Marketed from Aug 31, 2017 | |
| 70771-1115-1 | 70771111501 | 100 TABLET in 1 BOTTLE (70771-1115-1)Marketed from Aug 31, 2017 | |
| 70771-1115-3 | 70771111503 | 30 TABLET in 1 BOTTLE (70771-1115-3)Marketed from Aug 31, 2017 | |
| 70771-1115-4 | 70771111504 | 10 BLISTER PACK in 1 CARTON (70771-1115-4) / 10 TABLET in 1 BLISTER PACK (70771-1115-2)Marketed from Aug 31, 2017 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxazosin
- Generic name (nonproprietary)
- doxazosin
- Active ingredients
- Doxazosin mesylate — 8 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208719
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 70771-1115_466a6bd5-32e1-44ef-8220-90efc2e226d9SPL ID 466a6bd5-32e1-44ef-8220-90efc2e226d9SPL set ID ac889877-133c-4448-af5a-d77b3cbfe878RxCUI 197625, 197626, 197627, 197628UNII 86P6PQK0MU
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771111500followed by a unit qualifier and the quantityPackage 70771-1115-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 208719
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1112 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1113 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1114 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-831 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3965 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-783 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-784 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-785 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-786 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2395 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-4892 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | A-S Medication Solutions | 50090-3927 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3811 |